Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Drug Research Unit Ghent (DRU Ghent) is a specialized Phase 1 clinical research center located within the Ghent University Hospital in Belgium. Functioning as a full-service Contract Research Organization (CRO), the unit provides comprehensive support for early-phase clinical drug development to pharmaceutical and biotechnology companies. Its core expertise includes first-in-human trials, bioequivalence studies, and complex pharmacokinetic and pharmacodynamic assessments. The facility is equipped with a dedicated high-acuity ward for 24/7 monitoring of healthy volunteers and patient populations. DRU Ghent leverages its close integration with Ghent University to offer advanced scientific insights and high-quality data management. The unit operates under strict international Good Clinical Practice (GCP) standards, ensuring regulatory compliance for global drug submissions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Drug Research Unit Ghent.